Valuation: Bure Equity AB

Market Cap 23.45B 2.34B 2.09B 1.95B 1.77B 3.34B 224B 3.36B 9.18B 115B 8.78B 8.59B 371B P/E 2024
4.94x
P/E 2025 -3.91x
Enterprise Value 23.11B 2.3B 2.06B 1.92B 1.74B 3.29B 220B 3.31B 9.05B 114B 8.66B 8.47B 366B EV / Sales 2024
4.74x
EV / Sales 2025 -3.91x
Free-Float
70.39%
Yield 2024
0.72%
Yield 2025 1.11%
1 day+0.71%
1 week+1.49%
Current month-0.51%
1 month+2.55%
3 months+22.26%
6 months+37.09%
Current year+27.31%
1 week 305
Extreme 305
316.4
1 month 294.8
Extreme 294.8
325
Current year 190.2
Extreme 190.2
330.6
1 year 190.2
Extreme 190.2
330.6
3 years 190.2
Extreme 190.2
421.2
5 years 171.3
Extreme 171.3
474.6
10 years 86.8
Extreme 86.8
489.2
Manager TitleAgeSince
Chief Executive Officer 55 21/04/2013
Director of Finance/CFO 58 30/09/2013
Chief Investment Officer 46 31/12/2018
Director TitleAgeSince
Director/Board Member 56 29/04/2010
Chairman 62 21/04/2013
Director/Board Member 60 03/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Buy

Director

1,100 0.0015%
01/06/26 Buy

Chief Financial Officer

1,069 0.0014%
26/05/26 Buy 67,000 0.0904%
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%+1.49%+18.66%+35.78% 2.33B
0.00%+2.07%+33.37%+85.13% 125B
+0.20%-2.98%+32.82%+70.66% 21.71B
+0.37%-0.61%+21.59%+46.92% 16.34B
+1.96%+0.78%+16.52%+142.62% 15.27B
+0.27%+0.53%+15.15%+19.44% 14.03B
+0.36%+2.29%+77.41%+99.14% 13.59B
+0.24%+1.39%-11.15%+2.89% 13.06B
-0.06%+1.63%-10.49%+58.95% 12.42B
+0.82%+0.18%+19.21%+34.77% 12.28B
Average +0.48%+0.43%+21.31%+59.63% 24.63B
Weighted average by Cap. +0.25%+0.87%+27.47%+73.26%

Financials

2024 2025
Net sales 5.81B 579M 518M 483M 438M 827M 55.35B 832M 2.27B 28.56B 2.18B 2.13B 91.92B -4.6B -459M -411M -383M -347M -655M -43.86B -659M -1.8B -22.63B -1.72B -1.69B -72.83B
Net income 5.74B 573M 513M 478M 433M 817M 54.73B 823M 2.25B 28.24B 2.15B 2.1B 90.89B -4.68B -466M -418M -389M -353M -666M -44.59B -670M -1.83B -23.01B -1.75B -1.71B -74.05B
Net Debt -779M -77.68M -69.54M -64.82M -58.8M -111M -7.43B -112M -305M -3.83B -292M -285M -12.33B -339M -33.8M -30.26M -28.21M -25.59M -48.26M -3.23B -48.56M -133M -1.67B -127M -124M -5.37B
Projected Income Statement - Annual - Bure Equity AB
Logo Bure Equity AB
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Employees
12
Date Price Change Volume
12/10/26 SEK 314.20 +0.71% 51,812
09/10/26 SEK 312.00 +1.10% 60,546
08/10/26 SEK 308.60 -0.19% 56,763
07/10/26 SEK 309.20 -1.84% 63,584
06/10/26 SEK 315.00 +1.74% 74,899
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BURE Stock